Lack of covid vaccine down in NJ’s largest city, says Dr. Shereef Elnahal

Dr. Shereef Elnahal, president and CEO of University Hospital in Newark, New Jersey, told CNBC on Monday that a majority of people in the nearby community want the Covid vaccine, a move from earlier in the year. spread.

“There is a lot of skepticism, especially in communities of color and urban communities like the one we serve here in Newark,” the largest city in the state, Elnahal told the “Worldwide Exchange.” The good news, though, is that laziness is moving in the right direction. “

“We only had about 40% of the city of Newark and the surrounding area ready and willing to take the vaccine when it arrived. Now that number is closer to 60%,” said Elnahal, a former commissioner. health in New Jersey under Democratic Gov. Phil Murphy.

Elnahal’s comments come as the release of Covid vaccine in the U.S. accelerates.

On Saturday, a maximum of 2.9 million doses were given, according to the Centers for Disease Control and Prevention. In total, more than 90 million Covid doses have been given.

Overall, 17.7% of the U.S. population of more than 330 million people have received at least one dose, and 9.2% have received a full vaccine with both doses of the Pfizer or Moderna dual-dose regimen.

The Johnson & Johnson single – shot vaccine became the third to be licensed for emergency use by the U.S. Food and Drug Administration on Feb. 27.

The numbers of CDC vaccine controller still do not break down how many scenes of J&J were given, as it only started to spread in the US last week.

Although the pace of vaccination has risen in recent weeks and eligibility has widened, some health experts, such as former FDA Commissioner Dr. Scott Gottlieb, have warned that the lunch of Americans who want to get the bullet dry faster than expected.

“I think demand here … is deep but not widespread,” Gflieb, a board member of Pfizer, told CNBC last month. “There are probably, maybe, 100 million Americans who want this badly. Beyond that, we have to work on it.”

Shortly after the FDA cleared the Pfizer vaccine for emergency use, some hospital executives argued that delays even among their staff would disappear over time while dubious employees see their colleagues getting the pictures.

Indeed, the desire of the U.S. public to get the vaccine against Covid has skyrocketed in recent months. According to a Pew Research Center poll earlier this month, 69% expect to receive or have already received Covid vaccine. That’s an improvement from Pew’s decisions in November – a month before Pfizer or Moderna received formal approval from the FDA – that only 60% of Americans expected to receive the vaccine.

Censuses have shown that Black and Latino people are more relaxed about the vaccines than the U.S. as a whole because of historical maltreatment in treatment. Differences by ethnicity in vaccine circulation were observed in the US

Elnahal said University Hospital – a teaching hospital for Rutgers School of Medicine New Jersey – has reached out to several programs to try to build confidence in Covid vaccines.

“When we go through that door of trust and finally say, ‘Hey, we’re here with a potentially life-saving campaign,’ especially in a hit community so harsh, ”Elnahal said,“ we also stress that these three vaccines are 100% effective in preventing hospitalization and death [from Covid]. “

“That’s a huge amount, and in reality, these vaccines are better than so many others that have been on the market for a long time,” for other diseases, he said.

Disclosure: Scott Gottlieb is a CNBC Fellow and a board member of Pfizer, the start of genetic testing Tempus, Aetion healthcare tech company and biotech company Illumina. He is also his co-chair Norwegian tour line trends‘and Royal Caribbeanand “Healthy navigation panel.”

.Source